Fibrosis predicts post-surgical risk in aortic stenosis, reinforcing its role in guiding treatment decisions for both sexes.

If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.

As people age, a buildup of calcium on the aortic valve can make it thicker and stiffer leading to aortic stenosis. In addition, congenital heart defects, rheumatic fever, bacterial infections ...

Ataciguat, a new drug being studied for aortic valve stenosis, shows promise in slowing disease progression and reducing the ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

The current standard of care - watchful waiting - often leads to reduced quality of life before the condition is severe ...

In patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) with stable coronary ...

Varanasi: A team of skilled doctors at the Cardiology department at the Institute of Medical Sciences (IMS), Banaras Hindu ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...

may safely slow progression of valve calcification and potentially delay the need for intervention in patients with fibrocalcific aortic valve stenosis, new phase II data hint. Ataciguat, part of the ...

This multicenter study sheds more light on sex-based differences in aortic stenosis (AS) and argues the benefits of using cardiovascular magnetic resonance (CMR) to assess sex-based risks in AS.

Researchers have found in a new study that SGLT2 inhibitors may have disease-modifying effects in nonsevere aortic stenosis ...